IMA
ImageneBio, Inc.
Key Financials
Net Income
$-45349000
↑ 7.9%
Revenue
$800000
↓ 77.1%
Operating Income
$-48451000
↑ 17.8%
Total Liabilities
$19.8M
↑ 27.4%
Shareholders' Equity
$133.1M
↑ 5.7%
EPS (Diluted)
$-9.64
↓ 845.1%
Total Assets
$153.0M
↑ 8.1%
Cash & Equivalents
$94.5M
↑ 140.0%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
| undefined | Invalid Date | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IMA |
| Company Name | ImageneBio, Inc. |
| CIK | 1835579 |
| SIC Code | 2836 |
| SIC Description | Biological Products, (No Diagnostic Substances) |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | 857-343-8292 |